INSTRUCTIONS TO AUTHORS
Aims and Scope
Submission Process
The manuscript: File format | Length | Font | Heading | Footnotes
Title Page
Abstract
Introduction
Materials and Methods: Case Reports style | Short Communication style | Letters to the Editor style | Review articles style
Results
Discussion
Conclusion
Acknowledgments
Conflicts of interest
Graphical abstract
Tables
Figures
References
Proofreading
Abbreviations and symbols
The corresponding author
Ethical guidelines
Page charges
Copyright
Peer review process
Disposal of material
Equations
Abbreviations
Nomenclature
The Final Checklist
1. Aims and Scope:
Journal of Advances in Medical and Biomedical Research(J Adv Med Biomed Res) is a broad-based, bimonthly, Open Access and multidisciplinary journal which aims to promote and disseminate the knowledge by publishing high-quality peer-reviewed papers. The J Adv Med Biomed Res accepts Original articles, Short communications, Review articles, Case reports, and Letters to the Editors. The journal covers all areas of Medical Laboratory and Animal Investigation, Life Sciences, Pharmacology, Clinical Medicine, Epidemiologic Studies, Health Improvement Strategies, Bio-Nanotechnology, and Medical Biology.
Please see international Clinical Trials Registry Platform (ICTRP) published by WHO
2. Submission Process:
Submit your article by electronic submission via the Journal website URL: http://www.zums.ac.ir/journal. Each submission must be accompanied by a Cover Letter to the journal and include the Title, running title and the name of each author, and the undertaking that it has not been published or submitted elsewhere. In case the manuscript had been submitted to another Journal earlier and rejected, the authors must provide full information for proper analysis. For research articles providing Ethics Committee is necessary. Introduce 2-3 referees relating to the submitted manuscript.Be sure to mention the referee’s phone number in the relevant section. Referees should not be the same as authors. Manuscripts should be typed as double-spaced on an A4 size paper with clear 1-inch margins on both sides. Letter of Undertaking should be signed by all of the authors. All of the authors must have ORCID code.
In the case of the electronic submission, the authors must declare that the manuscript is being exclusively contributed to the J Adv Med Biomed Res. The text should be submitted in a Microsoft Word format as an attachment.
3. The manuscript:
As a general rule, all the submissions are expected to involve the following components:
Title Page; Abstract; Introduction; Materials and Methods; Results; Discussion; Conclusion Acknowledgement/s; and References.
Length: Original Article: 3000-4000 Words; Case Report: 2000-2500 Words, Short communication:
2500- 3000, Review Articles: 4000-5000 Words. (Excluding tables, figures and references list)
Font: Use a standard font size and any standard font, except for the font named “Symbol”. To add symbols to the manuscript, use the Insert → Symbol function in your word processor or paste in the appropriate Unicode character.
Heading: Limit manuscript sections and sub-sections to 3 heading levels. Make sure heading levels are clearly indicated in the manuscript text.
Footnotes: Footnotes are not permitted. If your manuscript contains footnotes, move the information into the main text or the reference list, depending on the content.
3.1
The Title Page: All submissions require a Title Page including the complete title of the manuscript, running title, the full names of all authors, with their highest academic degrees, the department or institution with which they are affiliated, and a full address for the corresponding author with phone number, as well as an e-mail address. All manuscript which submitted should have one corresponding author (Each article should have only one corresponding author). You should mention the corresponding author with (*) sign.Please be sure that the Orcid iDs written in the title page as well.
3.2 Abstract: All original articles must accompany a structured abstract up to 250 words. It should be structured into 4 labeled paragraphs as Background and Objectives, Materials and Methods, Results, and Conclusion (Narrative Review articles and Case Reports have non-structured abstracts but systematic review articles should be in structured format), as well as 3 to 5 Keywords at the bottom. Keywords will assist indexers in cross-indexing the article. Use terms from the Medical Subject Headings (MeSH) list of Index Medicus (http://www.nlm.nih.gov/mesh/MBrowser.html). The authors need to make sure that the abstract reflects the content of the manuscript accurately.
3.3 Introduction: This section should summarize the purpose and rationale for the study. However, it should neither review the subject extensively nor should it contain any data or conclusions.
3.4 Materials and Methods: This should include the materials used in the study, as well as well explained methods and experimental protocols. If an apparatus is used, its manufacturer’s name and City should be given in parenthesis. For well-established methods, give a reference and a brief description. However, if the method is new, give a detailed explanation so that another author is able to perform it. If a drug is used, its generic name, dose, and route of administration must be given. For patients’ sex and age, the mean age ± standard deviation must be given. Statistical method/s must be mentioned and data analysis software should be specified.
3.5 Results: This section must be presented in the form of body text, Tables, and Figures. The contents of the Tables should not be all repeated in the text. Long articles may need sub-headings within some sections (especially in the Results and Discussion parts) to clarify their contents.
3.6 Discussion: This section should emphasize the present findings and the variations or similarities with other works done in the field. The details of the data presented in the Results section should not be repeated in the discussion section again. Emphasize the new and important aspects of the study and the conclusions that follow from them. If a certain hypothesis was mentioned earlier to be tested in the study, it must be mentioned whether the hypothesis is true or false, or that no conclusion can be derived.
3.7 Conclusion: This section needs to mention separately from the discussion.
3.8 Acknowledgments: Financial and material support should be specified. All contributors who do not meet the criteria for authorship should be named in the acknowledgment section. This should include person/s who provided technical help and writing assistance.
3.9 Conflict of Interest: Declare conflicts of interest or state “The authors declare no conflict of interest.” Authors must identify and declare any personal circumstances or interest that may be perceived as inappropriately influencing the representation or interpretation of reported research results. Any role of the funders in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript, or in the decision to publish the results must be declared in this section. If there is no role, please state “The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results”.
3.10 Financial Support: Please add: “This research received no external funding” or “This research was funded by NAME OF FUNDER, grant number XXX.
3.11 Ethics and RCT code: Ethics code and its issuing reference should be mentioned.
3.12 Authors Contributions: Designate each author’s contribution using their initials.
For+ example: “Conceptualization, X.X. and Y.Y.; methodology, X.X.; software, X.X.; validation, X.X., Y.Y. and Z.Z.; formal analysis, X.X.; investigation, X.X.; resources, X.X.; data curation, X.X.; writing—original draft preparation, X.X.; writing—review and editing, X.X.; visualization, X.X.; supervision, X.X.; project administration, X.X.; funding acquisition, Y.Y”.
3.13 Graphical abstract : A graphical abstract should be included with the manuscript for display in the abstract. This graphic should be attractive to the reader and relevant to the manuscript title. Further, it should give the reader a prompt visual impression of the necessity of the manuscript with no specific results.
- It should be simple yet informative
- Colorful graphics are preferred
- The originality of graphics is required
- Use of graphics implying any bias to/against organizations or individuals should be avoided
- Graphics should be clear enough and the labels used inside it should be readable even in a very small font
- The graphical abstract file should be saved in TIFF or JPG with 300 dpi and 1200 dpi for respective color and black & white images
3.14Tables: Should be submitted in limited numbers with the captions placed above. Avoid submitting Tables as photographs. Place explanatory matters in the footnotes, not the heading. Note that tables should attach as word files, as well as in the main manuscript. Do not submit Tables as photographs.
3.15Figures: Should be in limited numbers, with high-quality artwork and mounted on separate pages. The Figure legends and captions should be placed below. The same data should not be presented in Tables, Figures, and the body text simultaneously.
(Figures and tables should be submitted all together in less than 5 per article and should be sent in the Manuscript file).
Please note that Figures must be submitted as separate files (in a Zip format), as well as in the main manuscript. All Figures must be submitted in separate files using JPEG or TIF format. All digitized images submitted with the manuscript must be of high quality; that is, resolutions of at least 300 dpi for color figures, 600 dpi for greyscales, and 1200 dpi for line arts.
·
Authors list:
List each author’s surname followed by a space and first name initial/s closed up without periods; include a hyphen if applicable. Separate each author’s name with a comma. Do not use and between the names. If there are 1 to 6 authors, list all of the names. If there are more than 6 authors, list the first 6 authors followed by “et al.”
Article:
Include the article title, Journal’s name (in italics and abbreviated according to Index Medicus), year of publication (followed by a semicolon), volume number (followed by a colon), and inclusive page numbers (followed by a period), as demonstrated in the following example:
1- Mortazavi Y, Merk B, McIntosh J, Marsh JC, Schrezenmeier H, Rutherford TR. The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH): a high incidence of multiple mutations and evidence of a mutational hot spot. Blood. 2003; 101(7): 2833-41.
·
Chapter:
Include the chapter title (capitalized sentence style and ending with a period), In: (followed by a space), any book editors (listed author-list style and ending with ed. or eds.), the book title, place, publisher, and year of publication, followed by a colon and the chapter’s page numbers, as shown in the following example:
Sallan SE, Weinstein HJ. Childhood acute leukemia. In: Nathan DG, Oski FA, eds. Hematology of Infancy and Childhood. Vol 2.
·
Book:
Include the book title (capitalized title style and ending with a period), place of publication (followed by a colon), publisher (followed by a semicolon and a space), and the year of publication, as shown by the example below:
1-
4. Proofreading:
An electronic article version is sent to the corresponding author for proofreading before publication in order to avoid unconscious mistakes. Corrections should be marked clearly and immediately sent back to the Journal office.
5. Abbreviations and symbols:
Use only standard abbreviations. Avoid using uncommon abbreviations in the Title and Abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is either very common (e.g. DNA) or it is a standard unit of measurement.
6. The corresponding author:
Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. The corresponding author should be marked with an asterisk after the name, and be written corresponding author’s e-mail below the first page of the manuscript. This responsibility includes answering any future queries about Methodology, Materials and the reviewers ‘comments, point by point. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author. Simultaneous listing of co-corresponding authors and co-first authors is not permitted.
7. Ethical guidelines:
Ethical considerations must be addressed in the Materials and Methods section. 1) Please state that informed consent was obtained from all human adult participants and from the parents or legal guardians of minors. Include the name of the appropriate institutional review board that approved the project. 2) Indicate in the text that the maintenance and care of experimental animals comply with National Institutes of Health guidelines for the humane use of laboratory animals, or those of your Institute or agency.
All medical research must be done considering the Helsinki Declaration of 1975, as revised in 2013. If the article is a clinical trial, you need to register with Iranian Registry of Clinical Trials (IRCT web-site) and mention the research (IRCT) number in the article.
8. Conflicts of interest:
Authors must acknowledge and declare any sources of funding and potential conflicting interest, such as receiving funds or fees by, or holding stocks and shares in, an organization that may profit or lose through publication of your paper. Declaring a competing interest will not necessarily lead to rejection of the paper, but we would like to be made aware of it.
9. Page charges:
There are no publication charges for this Journal.
10.Copyright Agreemenrt:
All of the authors should read the journal Copyright Agreement and Acknowledgement of Authorship Form and sign it clearly if agree, in order in which they appear in the manuscript. They can also use the electronic signature.
11. Defining the Role of Authors and Contributors:
1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2) Drafting the work or reviewing it critically for important intellectual content; AND
3) Final approval of the version to be published; AND
4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
For more information please check the ICMJE recommendations
12. Peer review process:
All manuscripts are considered to be confidential. Each manuscript is peer-reviewed by 3 anonymous referees elected by the Editorial Board. The corresponding author will be notified of the editor's decision to accept, reject, or any required modifications as soon as possible. If the manuscript is completely acceptable according to the criteria set forth in these instructions, it will be scheduled for publication in the next available issue.
13. Disposal of material:
Once published, all documents from the article, correspondence, and artwork will be held for 6 months before disposal.
14. Equations
We recommend using MathType for display and inline equations, as it will provide the most reliable outcome. If this is not possible, Equation Editor or Microsoft's Insert→Equation function is acceptable.
Avoid using MathType, Equation Editor, or the Insert→Equation function to insert single variables (e.g., “a² + b² = c²”), Greek or other symbols (e.g., β, Δ, or ′ [prime]), or mathematical operators (e.g., x, ≥, or ±) in running text. Wherever possible, insert single symbols as normal text with the correct Unicode (hex) values. Do not use MathType, Equation Editor, or the Insert→Equation function for only a portion of an equation. Rather, ensure that the entire equation is included. Equations should not contain a mix of different equation tools. Avoid “hybrid” inline or display equations, in which part is text and part is MathType or part is MathType and part is Equation Editor.
15. Abbreviations
Define abbreviations upon first appearance in the text. Do not use non-standard abbreviations unless they appear at least three times in the text. Keep abbreviations to a minimum.
16. Nomenclature
Use correct and established nomenclature wherever possible.
Units of measurement: Use SI units. If you do not use these exclusively, provide the SI value in parentheses after each value. Read more about SI units.
Drugs: Provide the Recommended International Non-Proprietary Name (rINN).
Species names: Write in italics (e.g., Homo sapiens). Write out in full the genus and species, both in the title of the manuscript and at the first mention of an organism in a paper. After the first mention, the first letter of the genus name followed by the full species name may be used (e.g., H. sapiens).
Genes, mutations, genotypes, and alleles: Write in italics. Use the recommended name by consulting the appropriate genetic nomenclature database (e.g., HGNC for human genes; we strongly recommend using this tool to check against previously approved names). It is sometimes advisable to indicate the synonyms for the gene the first time it appears in the text. Gene prefixes such as those used for oncogenes or cellular localization should be shown in roman typeface (e.g., v-fes, c-MYC).
Allergens: The systematic allergen nomenclature of the World Health Organization/International: union: of Immunological Societies (WHO/IUIS) Allergen Nomenclature Sub-committee should be used for manuscripts that include the description or use of allergenic proteins. For manuscripts describing new allergens, the systematic name of the allergen should be approved by the WHO/IUIS Allergen Nomenclature Sub-Committee prior to manuscript publication. Examples of the systematic allergen nomenclature can be found at the WHO/IUIS Allergen Nomenclature site.
17. Case Reports style:
Case reports will be considered only if they represent a significant advance in diagnostic methods, therapy, and prognosis or highlight substantial scientific advances in understanding the mechanism(s) of the disease process. All Case Report articles must accompany unstructured abstract between 100-150 words. They should be prefaced by a brief introduction, highlighting the salient message, and their discussion should be confined to unusual aspects, not a major review of the literature. They should be arranged on follows: Title page, Introduction, Case Report, Discussion, References, and legends. For case report article write 7-15 references.
18. Short Communication style:
There will be special arrangements for rapid communications that will justify very rapid publication because of their exceptionally broad general interest or strikingly novel findings. The submitted paper should be self-contained and not a tentative preliminary communication. It will be referred to very quickly and any revision must be dealt with promptly. It is expected that the time interval between the acceptance and subsequent publication of the manuscript will be approximately 3 months. If the editors consider the article unsuitable for publication as a rapid communication it will be processed as a normal paper unless the authors withdraw it.
19. Letters to the Editor style:
Relating to papers recently published in the Journal, or containing brief reports of unusual or preliminary findings . Maximum length 400 words, one table or figure and 7-10 references.
20. Review articles style:
Review articles, solicited and unsolicited, are actively encouraged and should be composed of systematic, critical assessments of literature and data sources pertaining to diagnostic topics. All articles and data sources reviewed should include information about the specific type of study or analysis. Review articles must accompany unstructured abstracts. Systematic review articles should be in a structured format. References for review articles should be in less than 100.
The Final Checklist
Authors must ensure that before submitting the manuscript for publication, they have taken care of the following:
1. Title Page should contain the manuscript Title, names of all authors, with their highest academic degrees, as well as the designation and institutions they are affiliated with, and the name of the corresponding author with a mailing address, for future correspondence, as well as an E-mail address, plus Phone and Fax numbers.
2. All Original article abstracts should be in structured format up to 250 words, Case reports in an unstructured format up to 100-150 words, Review articles in an unstructured format (systematic review should be in a structured format).
3. References formatted as stated in the Instructions to Authors section.
4. Tables and Figures should be in the text of the manuscript and submitted all together in less than 6 per article.
5. Make sure to number all Tables and Figures and include the appropriate headings, captions, and legends. Avoid repeating the information shown in Figures and Tables in the text.
6. Photographs/ illustrations along with their captions.
7. Letter of Undertaking signed by all of the authors.
8. Disclosure statement regarding the source of funding and conflicts of interest, if any, besides approval of the study from respective Ethics Committee/Institution Review Board when necessary.
9. Cover Letter.
Attention:
1- All the manuscripts are checked for Plagiarism using iThenticate services.
2- All the manuscripts after the completion of the plagiarism process should be edited by Native English Editors.
3. Once the article has been accepted for publication, no changes will be made to the order of the authors' names and their academic addresses.
Copyright Policy
